Sonia Franco

7.8k total citations · 1 hit paper
59 papers, 4.7k citations indexed

About

Sonia Franco is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Sonia Franco has authored 59 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 24 papers in Oncology and 20 papers in Physiology. Recurrent topics in Sonia Franco's work include DNA Repair Mechanisms (19 papers), Telomeres, Telomerase, and Senescence (19 papers) and Genetics, Aging, and Longevity in Model Organisms (9 papers). Sonia Franco is often cited by papers focused on DNA Repair Mechanisms (19 papers), Telomeres, Telomerase, and Senescence (19 papers) and Genetics, Aging, and Longevity in Model Organisms (9 papers). Sonia Franco collaborates with scholars based in United States, Spain and France. Sonia Franco's co-authors include Frederick W. Alt, Monica Gostissa, Marı́a A. Blasco, David B. Lombard, John Manis, Katrin F. Chua, Raúl Mostoslavsky, Michael Murphy, Ali A. Zarrin and Catherine T. Yan and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Sonia Franco

56 papers receiving 4.7k citations

Hit Papers

DNA Repair, Genome Stabil... 2005 2026 2012 2019 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonia Franco United States 30 3.0k 1.2k 1.0k 784 498 59 4.7k
Raffaella Di Micco Italy 18 3.3k 1.1× 1.6k 1.3× 947 0.9× 774 1.0× 749 1.5× 31 4.9k
Peggie Cheung United States 22 2.9k 1.0× 1.3k 1.0× 485 0.5× 506 0.6× 248 0.5× 27 4.3k
Olga Chernova United States 27 2.2k 0.7× 635 0.5× 1.1k 1.1× 546 0.7× 565 1.1× 42 3.7k
Jessica E. Bolden Australia 14 3.7k 1.2× 806 0.6× 1.2k 1.1× 841 1.1× 448 0.9× 17 4.9k
Ezra Vadai Israel 23 1.6k 0.5× 1.2k 1.0× 716 0.7× 1.5k 1.9× 297 0.6× 44 3.5k
Tej K. Pandita United States 46 5.2k 1.7× 1.1k 0.9× 1.3k 1.2× 272 0.3× 969 1.9× 125 6.4k
Eric Kenneth Parkinson United Kingdom 32 1.8k 0.6× 933 0.8× 737 0.7× 370 0.5× 602 1.2× 92 3.3k
Monther Abu-Remaileh United States 25 3.2k 1.1× 721 0.6× 399 0.4× 385 0.5× 1.0k 2.1× 40 4.8k
Patricia A. Kruk United States 27 2.1k 0.7× 526 0.4× 582 0.6× 300 0.4× 1.0k 2.1× 55 3.2k
Daisuke Nakada United States 31 3.5k 1.2× 387 0.3× 593 0.6× 508 0.6× 1.1k 2.2× 76 4.9k

Countries citing papers authored by Sonia Franco

Since Specialization
Citations

This map shows the geographic impact of Sonia Franco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonia Franco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonia Franco more than expected).

Fields of papers citing papers by Sonia Franco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonia Franco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonia Franco. The network helps show where Sonia Franco may publish in the future.

Co-authorship network of co-authors of Sonia Franco

This figure shows the co-authorship network connecting the top 25 collaborators of Sonia Franco. A scholar is included among the top collaborators of Sonia Franco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonia Franco. Sonia Franco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Powles, Thomas, Enrique Grande, Nimira Alimohamed, et al.. (2025). SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinoma. Future Oncology. 21(21). 2705–2712. 1 indexed citations
2.
Smith, Angela B., John L. Gore, Haojie Li, et al.. (2025). Muscle invasive bladder cancer treatment selection in an emerging treatment era: A patient preference study.. Journal of Clinical Oncology. 43(5_suppl). 753–753.
3.
Galsky, Matt D., Enrique Grande, Andrea Necchi, et al.. (2024). Phase 3 study of disitamab vedotin with pembrolizumab vs chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001).. Journal of Clinical Oncology. 42(16_suppl). TPS4616–TPS4616.
4.
6.
Loriot, Yohann, Petros Grivas, Ronald de Wit, et al.. (2022). First-line pembrolizumab (pembro) with or without lenvatinib (lenva) in patients with advanced urothelial carcinoma (LEAP-011): A phase 3, randomized, double-blind study.. Journal of Clinical Oncology. 40(6_suppl). 432–432. 18 indexed citations
7.
Park, Youngran, M. Herman Chui, Yohan Suryo Rahmanto, et al.. (2019). Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy. Clinical Cancer Research. 25(18). 5584–5594. 95 indexed citations
8.
Bhatt, Niraj, Rajib Ghosh, Sanchita Roy, et al.. (2016). Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T). Stem Cell Research. 17(2). 205–207. 1 indexed citations
10.
Reynolds, Taylor L., et al.. (2013). 53BP1 Is Limiting for NHEJ Repair in ATM-deficient Model Systems That Are Subjected to Oncogenic Stress or Radiation. Molecular Cancer Research. 11(10). 1223–1234. 13 indexed citations
11.
Franco, Sonia, et al.. (2008). DNA-PKcs and Artemis function in the end-joining phase of immunoglobulin heavy chain class switch recombination. The Journal of Experimental Medicine. 205(3). 557–564. 78 indexed citations
12.
Takizawa, Makiko, Zhiyu Li, Wendy Dubois, et al.. (2008). AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. The Journal of Experimental Medicine. 205(9). 1949–1957. 108 indexed citations
13.
Yan, Catherine T., Cristian Boboilă, Sonia Franco, et al.. (2007). IgH class switching and translocations use a robust non-classical end-joining pathway. Nature. 449(7161). 478–482. 450 indexed citations
14.
Franco, Sonia, Monica Gostissa, Shan Zha, et al.. (2006). H2AX Prevents DNA Breaks from Progressing to Chromosome Breaks and Translocations. Molecular Cell. 21(2). 201–214. 224 indexed citations
15.
Otero, Antonío, Juan Fernández‐Baeza, Antonío Antiñolo, et al.. (2006). Design of new heteroscorpionate ligands and their coordinative ability toward Group 4 transition metals; an efficient synthetic route to obtain enantiopure ligands. Dalton Transactions. 4359–4370. 36 indexed citations
16.
Franco, Sonia, Andrés Canela, Peter Klatt, & Marı́a A. Blasco. (2005). Effectors of mammalian telomere dysfunction: a comparative transcriptome analysis using mouse models. Carcinogenesis. 26(9). 1613–1626. 10 indexed citations
17.
Lombard, David B., Katrin F. Chua, Raúl Mostoslavsky, et al.. (2005). DNA Repair, Genome Stability, and Aging. Cell. 120(4). 497–512. 720 indexed citations breakdown →
18.
Maraval, Alexandrine, et al.. (2003). Porphyrin–aminoquinoline conjugates as telomerase inhibitors. Organic & Biomolecular Chemistry. 1(6). 921–927. 45 indexed citations
19.
Franco, Sonia, Manfred Alsheimer, Eloı́sa Herrera, Ricardo Benavente, & Marı́a A. Blasco. (2002). Mammalian meiotic telomeres: composition and ultrastructure in telomerase-deficient mice. European Journal of Cell Biology. 81(6). 335–340. 23 indexed citations
20.
MacKenzie, Karen L., Sonia Franco, Afzal J. Naiyer, et al.. (2002). Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. Oncogene. 21(27). 4200–4211. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026